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Background: Physicochemical characteristics of liposome/DNA complexes influence transfec-
tion efficiency and affect each other in a very intricate way. The result of this is discrepancies 
in conclusions drawn about the individual influence of each one.
Methods: Aiming to elucidate the influence of liposome/DNA charge ratio and size on trans-
fection efficiency and on each other, we used liposome/DNA complexes with charge ratio (+/−) 
in the range of 1–50 and extruded through membranes of 400, 200, and 100 nm. Plasmid DNA 
encoding green fluorescent protein was used to measure transfection efficiency by flow   cytometry. 
Sizes of liposome/DNA complexes were measured by dynamic light scattering.
Results: Liposome size was reduced after extrusion but this was mainly driven by the charge 
ratio and not by the size of the membrane pores. Reduction of complex size at each charge ratio 
positively correlated with transfection efficiency. When the size of the complexes was 
approximately constant, increasing the charge ratio was found to promote transfection efficiency. 
Cationic lipid N-(1-(2,3-dioleoyloxy)propyl)N,N,N trimethylammonium chloride was used for 
modulation of positive charge and a cytotoxicity test showed that increasing its amount increases 
cytotoxicity.
Conclusion: It can be concluded that charge ratio dictates the size of the complex whereas 
overall size reduction and higher charge ratios promote transfection efficiency in vitro.
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Introduction
Gene therapy is defined as induction or inhibition of genes by means of introducing 
various forms of nucleic acids into cells. Since the entry of nucleic acids into cells 
is a very inefficient process, successful gene therapy requires an efficient drug 
delivery system. Viral vectors and nonviral delivery systems are used for delivery 
of nucleic acids into cells. Viral vectors are very efficient in introducing genes into 
cells but have limitations regarding the size of the genes that can be delivered and 
the safety of such formulations. Alternatively, nonviral delivery systems are much 
safer and not limited in their delivery of large pieces of DNA but are often not 
sufficiently efficient.1–3 Nonviral delivery systems include various physical modes 
of delivery (eg, gene gun, electroporation, hydrodynamic delivery, and ultrasound) 
whereas chemical systems include various cationic polymers and cationic liposomes.4,5 
The most frequently used nonviral systems are liposomes as can be seen from the 
proportions of vectors used in clinical trials.6 Cationic liposomes interact with nega-
tively charged nucleic acids and these complexes enter the cell by endocytosis, then 
fuse with endosomal membranes and release nucleic acids into the cytoplasm.7–11 
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  Liposomes have been investigated for over 20 years as 
delivery systems for nucleic acids, but the process is not 
fully understood and depends on various physicochemical 
characteristics of the liposome/DNA, such as size,12–15 
lamellarity,16 structure,17 fusogenicity,18 charge ratio,13,14,19 
and charge density.20 Furthermore, these properties often 
influence each other, further complicating the picture.21,22 
Also, various studies have been conducted with the aim of 
synthesizing new cationic lipids with improved properties 
and studying structure-activity relationships.23,24 However, 
since various factors influence the transfection efficiency, 
it is difficult to draw a definite conclusion about the influ-
ence of structural characteristics of lipids and physico-
chemical properties of liposome/DNA complexes on 
transfection efficiency. Finding an effective formulation 
thus remains mostly a process of trial and error.
The aim of this study was to systemically investigate 
liposome/DNA formulations differing in lipid composition, 
size, and charge ratio and to define the most effective 
  liposome/DNA characteristics promoting transfection effi-
ciency in vitro. Such a study was undertaken as a preliminary 
screening for the best formulation to be studied in a future 
design of a liposome/DNA vaccine and investigation of its 
efficacy in vivo. To monitor transfection efficiency we used 
plasmid DNA encoding-enhanced green fluorescent protein 
(pEGFP) and the percentage of green fluorescent protein 
(GFP)-  expressing cells was determined by flow cytometry. 
It was incorporated into three differently composed liposomal 
formulations: (1) phosphatidylcholine (PC), 1,2-dioleoyl-
  sn-glycero-3 phosphatidylethanolamine (DOPE) and 
N-(1-(2,3-dioleoyloxy)propyl)N,N,N trimethylammonium 
chloride (DOTAP); (2) DOPE and DOTAP; (3) PC, choles-
terol (CHOL), and DOTAP. In addition, the charge ratio was 
varied from 1 to 50 by changing the quantities of positive 
lipid (DOTAP) in the process of liposome preparation. 
  Lipoplexes were sized using extrusion through a membrane 
of appropriate pore size. Charge ratios well above those 
usually studied (1–10) were investigated here since it has 
already been shown that liposome/DNA complexes have 
better transfection efficiency with higher charge ratios 
(+/− ≈ 15),25 presumably due to the existence of free 
  liposomes.26 Interestingly, as far as we are aware, the higher 
ratios have not been studied before, so this is the first such 
study. The obtained charge and size of the formulated lipo-
some complexes were subsequently monitored by dynamic 
light scattering. In addition, lipoplexes were prepared 
by hydrating lipid films directly with DNA solution and not 
by mixing of the preformed liposomes and DNA as is usually 
the method employed in preparing complexes. Our results 
show that after extrusion of liposome complexes, their size 
is decreased, but is mainly governed by the charge ratio. Also, 
increase in charge ratio and decrease in size of complexes 
improved transfection efficiency. Cytotoxicity of liposomal 
preparations was determined using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium (MTT) cell viability assay and 
it was found that with increasing amount of DOTAP cyto-
toxicity also increased.
Materials and methods
Chemicals
The DOPE, PC, and DOTAP were from Avanti Polar Lipids 
(Alabaster, AL). CHOL and MTT were from Sigma 
(St Louis, MO). Aliquots of lipids were stored as a chloro-
form stock solution at −20°C. Dimethyl sulfoxide was from 
Merck (Darmstadt, Germany). All other chemicals were from 
Kemika (Zagreb, Croatia).
Plasmid DNA (pDNA) encoding pEGFP was from 
  Clontech (Mountain View, CA). The pDNA was purified on 
a DEAE CIM disk from BIA Separation (Ljubljana, Slovenia) 
as previously described.27 The concentration and purity of 
the pDNA was determined by the ratio A260/280 and by 
agarose gel electrophoresis.
Liposome/DNA preparation
Thin lipid films were obtained by rotary evaporation of chlo-
roform lipid solution in round-bottom flasks. Evaporation and 
rehydration of lipid films (8.44 mg) was performed at 37°C. 
Rehydration was performed with 1.35 mL pEGFP solution 
(30 µg/mL) in phosphate-buffered saline (PBS) (10 mM 
phosphate buffer pH = 7.4 with 0.15 M NaCl). In three com-
ponent systems the amount of PC was twice that of the other 
helper lipid and the amount of DOTAP was directed by the 
charge ratio. This setup resulted in the following lipid molar 
ratios (charge ratios are denoted in square brackets): 
  PC-DOPE-DOTAP [1] 2-1-0.04, PC-DOPE-DOTAP [10] 
2-1-0.5, PC-DOPE-DOTAP [25] 2-1-1.3, PC-DOPE-DOTAP 
[50] 2-1-4.3, PC-DOPE [50] 1-1.4, PC-CHOL-DOTAP [50] 
1-1-2.25. To reduce the size of the lipoplexes, some of the 
lipoplex preparations were extruded (29×) through polycar-
bonate membranes of specific pore size using a LipoFast 
extruder from Avestin (Ottawa, Canada).
Cell culture
The following cell lines were used: 293T cells (SV40 
T-antigen expressing human kidney cells), COS7 (SV40 
transformed African green monkey kidney cells), and Vero 
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cells (normal African green monkey kidney cells). All cell 
lines were purchased from the American Type Culture 
  Collection (ATCC). The cells were cultivated in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 
10% fetal calf serum (Moregate Biotech, Australia) and 
neomycin 50 µg/mL (Gibco Invitrogen Corporation, CA) 
and incubated at 37°C in a humidified atmosphere of 5% CO2. 
The cells were trypsinized (0.25%) every 3–4 days and 
further subcultivated by splitting them in a ratio of 1:6.
Lipofection procedure
Cells were seeded in six well plates (2.5 × 105 cells/well) in 
complete medium at 37°C in a humidified atmosphere con-
taining 5% CO2. After 24 hours cells were washed with 
DMEM once and liposome/DNA complexes (500 µL) plus 
500 µL DMEM were added. After 3 hours at 37°C in a 
humidified atmosphere containing 5% CO2 , the transfection 
solution was replaced with complete medium and cells were 
further cultured for 48 hours. As a positive control, 5 × 105 
cells were electroporated at (700 V , 450 µs, 1×) in a 4 mm 
gap cuvette (Multiporator, Eppendorf, Germany) with 
pEGFP and cultivated for 48 hours.
Measurement of transfection efficiency  
by flow cytometry
Electroporated or lipofected cells were trypsinized, washed 
once with complete medium, and then once with PBS. Cells 
were resuspended in 500 µL of PBS supplemented with 
0.1% sodium azide and 2% fetal calf serum and analyzed 
on a FACSCalibure flow cytometer (Becton Dickinson, 
Franklin Lakes, NJ).
Cytotoxicity
293T cells were seeded in a 96-well plate (1 × 104 cells/
well) and cultured in complete medium at 37°C in a 
humidified atmosphere containing 5% CO2. After 24 hours, 
liposome/DNA complexes (50 µL) plus 50 µL DMEM 
were added. After 3 hours complexes were removed and 
200 µL of complete medium was added. Cells were culti-
vated for a further 48 hours at 37°C in a humidified atmo-
sphere containing 5% CO2. Medium was removed and 
subsequently 50 µL of MTT (0.5 mg/mL) was added and 
cells were cultivated for another 4 hours. Formed formazan 
crystals were dissolved by addition of 200 µL dimethyl 
sulfoxide. The plates were read on a ThermoScientific 
microplate spectrophotometer (Thermo Fisher Scientific, 
MA) at 580 nm and at 680 nm as a reference wavelength. 
Samples were assayed in tetraplicate.
Size and charge of liposome/DNA 
complexes
Liposome size and zeta potential were measured by dynamic 
light scattering using Zetasizer Nano ZS (Malvern 
  Instruments, Malvern, UK) equipped with 532 nm “green” 
laser. Liposomal formulations for zeta and size measurements 
were diluted with PBS to a final concentration 0.125 mg/mL. 
Size of lipoplexes is expressed as an average diameter 
(z-average) that is obtained from the Zetasizer Nano software 
using intensity derived size distribution. For comparison of 
results, the diameter of the major population obtained from 
number-derived size distribution was taken into account. 
Three   separate preparations were analyzed, each measured 
three times.
Results
Influence of the charge ratio on the size 
of extruded liposome/DNA complexes
Size and charge ratio (ratio of number of positive charges 
originating from cationic lipid and number of negative charges 
from DNA’s phosphates) of liposome/DNA complexes are 
considered very important physicochemical characteristics for 
transfection efficiency of formulation.12–15,19 We prepared lipo-
plexes (PC-DOPE-DOTAP) with charge ratios 1, 10, 25, and 
50 by varying the amount of DOTAP. To investigate the influ-
ence of the size of liposome/DNA complexes on the transfec-
tion efficiency we extruded lipoplexes through membranes 
with various pore sizes: 100, 200, and 400 nm. Sizes of 
  liposome/DNA complexes were measured by dynamic light 
scattering. Size measured by dynamic light scattering can be 
given as a number distribution, volume distribution, or inten-
sity distribution and mean diameter (z-average) which is 
calculated from intensity distribution using a non-negatively 
least squares algorithm (software provided by the   manufacturer) 
and these results can differ from each other. Dynamic light 
scattering results revealed that tested liposomal formulations 
were not 100% homogenous in size but rather contained one 
major vesicle population (generally comprising more than 
90% of all vesicles). Therefore, we processed results from 
number distributions (we took into account the largest size 
population which was generally above 90%) and compared 
them to z-average. It should be noted that three measurements 
of the same sample expressed as z-average had lower standard 
deviations then the mean size of the major population from 
number distributions. The trend of liposome size in respect to 
charge ratio was the same for both, mean diameter and number 
distribution, but the values of mean diameters were always 
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Figure 1 Size of PC-DOPE-DOTAP/pEGFP complexes measured by dynamic light scattering.
Notes: Results are expressed as z-average (av) or as size of major population from number distribution (nu). (A) size of extruded complexes. (B) size of unextruded 
complexes. Results are expressed as mean ± standard deviation of three separate experiments. Each sample was measured three times.
Abbreviations:  PC,  phosphatidylcholine;  DOPE,  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine;  DOTAP,  N-(1-(2,3-dioleoyloxy)propyl),N,N,N-trimethylammonium 
chloride; pEGFP, plasmid (encoding) enhanced green fluorescent protein.
higher (Figure 1). Liposome size of extruded formulations was 
reduced in comparison to unextruded, however it was not 
determined by the size of membrane pores but by the charge 
ratio. The mean diameters of all preparations (PC-DOPE-
DOTAP), regardless of membrane pore size, with charge ratio 
50, 25, 10, and 1 were 561 ± 29.7, 727 ± 74.0, 1477 ± 100.3, 
and 7121 ± 942.2 nm, respectively. Increase in charge ratio 
resulted in decrease in the size of liposome/DNA complex. 
Sizes of complexes that were not extruded (Figure 1B) did not 
show any trend but this might be because they were very large 
and on the upper limit of the instrument measurement ability 
(in some runs the instrument could not even measure the sizes 
of these large complexes) so precision of obtained results is 
quite low. Interestingly, liposome/DNA complexes with 
charge ratio 50 and 25 (regardless of composition or extrusion) 
after ultracentrifugation (300, 000 × g) and also after a period 
of no disturbance in a container floated at the surface whereas 
lipoplexes with charge ratio 10 and 1 settled at the bottom of 
the cuvette. Zeta potential of liposomal preparations was also 
measured. It can be seen that the zeta potential was governed 
by the charge ratio and was not changed by extrusion as could 
be expected (Table 1).
Influence of liposome composition, 
charge ratio, and size of the liposome/
DNA complex on transfection efficiency
Since it is well known that lipid composition and structure of 
lipids can influence transfection efficiency we investigated 
three formulations; PC-DOPE-DOTAP, DOPE-DOTAP, and 
PC-CHOL-DOTAP. We used pEGFP to asses transfection 
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Table 1 Zeta potential of PC-DOPE-DOTAP/pEGFP complexes 
before and after extrusion. Complexes were prepared by hydration 
of  thin  lipid  film  with  pEGFP  solution,  which  were  extruded 
through membranes with 100 nm pores
Charge ratio Zeta potential/mV
Unextruded 100 nm
50 38.7 ± 0.89 37.7 ± 0.66
25  26.1 ± 2.05 27.1 ± 2.38
10 14.8 ± 1.49 15.2 ± 2.97
1 −2.8 ± 0.85   0.3 ± 1.69
Notes: Measurements were performed in PBS, and the final concentration was 
0.125 mg/mL. Results are expressed as mean ± standard deviation of three separate 
experiments. Each sample was measured three times. 
Abbreviations:  PC,  phosphatidylcholine;  DOPE,  1,2-dioleoyl-sn-glycero-3- 
phosphoethanolamine; DOTAP, N-(1-(2,3-dioleoyloxy)propyl),N,N,N-trimethylamm-
onium chloride; pEGFP, plasmid (encoding) enhanced green fluorescent protein; PBS, 
phosphate-buffered saline.
efficiency of liposomal formulations which was measured by 
flow cytometry. Results were expressed as a percentage of 
cells expressing GFP. We have tested liposome/pEGFP for-
mulations in three different types of cells (Vero, COS7, and 
293T). The best transfection results were obtained in 293T 
cells (Figure 2) so they were used throughout this work. We 
used DOTAP as cationic lipid as it is the most widely used 
lipid for lipofection.28 As neutral (helper) lipids we used PC, 
DOPE, and CHOL. DOPE is known to be fusogenic and 
promotes transfection efficiency in vitro29,30 whereas CHOL 
decreases fluidity of the bilayer, increases stability, and is 
considered to be more efficient in vivo;25,31 and in the presence 
of serum.32 Also, we used three-component systems since it 
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Figure 2 Transfection efficiency of lipoplexes and electroporation in different cell types.
Notes: Liposomal formulation: PC-DOPE-DOTAP/pEGFP complex, charge ratio 
50, extruded through 100 nm membranes (light gray columns); electroporation 
(dark gray columns). Results are expressed as mean ± standard deviation of at least 
three separate experiments.
Abbreviations: PC, phosphatidylcholine; DOPE, 1,2-dioleoyl-sn-glycero-3-phos-
phoeth  anolamine;  DOTAP,  N-(1-(2,3-dioleoyloxy)propyl),N,N,N-trimethylam-
monium chloride; pEGFP, plasmid (encoding) enhanced green fluorescent protein.
has been shown that multicomponent systems may also pro-
mote transfection efficiency of liposome/DNA   complexes.33 
PC-DOPE-DOTAP formulation was prepared with charge 
ratios 1, 10, 25, and 50 while DOPE-DOTAP and PC-CHOL-
DOTAP were prepared only at ratio 50. Liposome/pEGFP 
complexes were prepared by hydration of thin lipid film which 
yields large vesicles and these preparations were extruded to 
reduce the size. Zeta potential and size of prepared formula-
tions are shown in Figure 1 and Tables 1 and 2. PC-DOPE-
DOTAP/pEGFP complexes showed increase of transfection 
efficiency upon increase of charge ratio and reduction of the 
size of liposome/DNA complexes (Figure 3). Lipoplexes 
composed of DOPE-DOTAP were investigated regarding 
size but only at charge ratio 50 and showed the best efficiency 
of all formulations tested (Figure 3). We did not investigate 
DOPE-DOTAP formulations at other charge ratios in more 
detail because preliminary experiments showed that these 
formulations strongly adhered to flasks and were very hard 
to hydrate and resuspend with DNA solution, although these 
experiments also showed a trend of increase in transfection 
efficiency with increase in charge ratio (data not shown). 
Results from transfection efficiency experiments with DOPE-
DOTAP formulations showed that size reduction of com-
plexes resulted in enhancement of transfection efficiency 
(Figure 3). In the case of formulations consisting of PC-
CHOL-DOTAP it was shown that decrease in size resulted in 
just a slight increase in transfection efficiency (Figure 3). 
To   conclude, for different liposome compositions, size 
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Figure 3 Influence of composition, size, and charge ratio on transfection efficiency 
of complexes in 293T cells.
Notes: Lipoplexes were prepared by hydration of thin lipid film with pEGFP solution 
(light gray columns), which were extruded through membranes with 100 nm pores 
(dark gray columns). Results are expressed as mean ± standard deviation of at least 
three separate experiments. Number in brackets denotes the charge ratio.
Abbreviations: PC, phosphatidylcholine; DOPE, 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine; DOTAP, N-(1-(2,3-dioleoyloxy)propyl),N,N,N-trimethylammonium 
chloride; pEGFP, plasmid (encoding) enhanced green fluorescent protein; CHOL, 
cholesterol.
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  reduction (from micrometer to nanometer sizes, Figure 1 and 
Table 2) improved transfection efficiency which was most 
evident for PC-DOPE-DOTAP complexes while slightly 
lower for DOPE-DOTAP and the lowest for PC-CHOL-
DOTAP.
Cytotoxicity of liposome/DNA 
complexes
Cytotoxicity of liposome/DNA complexes was determined 
using MTT assay. The viability of untreated cells (positive 
control) was set to 100%. The viability of negative control 
cells (treated with water) was only 10%. Increasing charge 
ratio of liposomal formulations ie, higher amount of DOTAP 
(in PC-DOPE-DOTAP) increased cytotoxicity of liposome/
DNA complexes and caused cell viability decrease from 90% 
for charge ratio 1 to 50% for charge ratio 50 (Figure 4). Also, 
in two other formulations,   DOPE-DOTAP and PC-CHOL-
DOTAP with charge ratio 50, toxicity was 40% and 43%, 
respectively. Furthermore, we observed that liposome/DNA 
complexes exhibit greater cytotoxicity than liposomes alone 
(data not shown) as   previously published by Nguyen et al.34
Discussion
A large amount of research has been conducted with the aim 
of defining physicochemical characteristics of liposome/DNA 
complexes leading to better transfection efficiency. Overall, 
it can be only concluded that characteristics of liposome/DNA 
complexes influence the efficiency of liposomes as delivery 
systems and additionally influence each other so it is very 
difficult to unambiguously define superior characteristics 
leading to superior efficiency. In the presented work we 
wanted to explore the efficiency of liposome/DNA   complexes 
with higher charge ratios up to 50 since usually only charge 
ratios in the range from 1 to 10 have been   investigated. 
  Furthermore, we wanted to characterize and define liposomal 
formulations with respect to charge and size.
Regardless of the method used for mammalian cell 
transfection, it is important to optimize transfection   conditions. 
This includes the optimization of the liposome/DNA formula-
tion and the ratio of the formulation to medium for every cell 
type used. In order to avoid a protracted optimization process 
we tested three robust cell lines (Vero, COS7, and 293T), 
which are well known for their susceptibility to transfection 
and are therefore often used experimentally for generation of 
either transient or stable transformants. As shown in   Figure 2 
these cell lines display different susceptibilities for transfec-
tion when electroporation and lipofection were conducted 
under conditions described herein. 293T cells were transfected 
to an almost identical level by both methods so for further 
experiments we decided to use this cell line.
Results shown in Figure 1 demonstrate that the size of 
liposome/DNA complexes was reduced after extrusion but 
is very dependent on the charge ratio and not so much on the 
pore size of extrusion membrane since regardless of the pore 
size (400, 200, or 100 nm) liposome size was about the same 
for certain charge ratios. Increase in the size of complexes 
approaching equivalence point and decrease at higher and 
lower charge ratios (8–0.5) have already been observed by 
Xu et al, except that only charge ratios up to 8 were used.35 
Furthermore, we have observed that lipoplexes with higher 
charge ratios floated after ultracentrifugation and those with 
smaller charge ratios sedimented. Xu et al found that on 
sucrose gradient position of the band corresponding to 
lipoplexes was determined by charge ratio.35 Increase in 
complex size when the zeta potential approached zero was 
also observed by Birchall et al. This group studied charge 
ratios in the range of 2.8–0.8 (+/−).36 The same effect was 
also reported for charge ratios 6–0.125.13,14 Taken together it 
can be concluded that charge ratio influences the size of 
complexes and moreover it does so even after extrusion 
through membranes.
Influence of charge ratio on transfection efficiency of 
lipoplexes has also been investigated. Some report a peak of 
the transfection efficiency being above a charge ratio of 2.3 
but only in one type of cell whereas in the other type the 
transfection efficiency seemed not to be influenced by the 
charge ratio.36 There are some reports that the highest trans-
fection efficiency is at a charge ratio of 1.5 and decreasing 
at higher and lower charge ratios.13 Liu et al reported that the 
charge ratio of 15.9 (corresponding to 48 nmol: 1 µg) is best 
in the range 0.33 to 15.9 when studied in vivo.19 Some reports 
Table 2 Size and zeta potential of liposome/pEGFP complexes
DOPE-DOTAP PC-CHOL-DOTAP
Zeta potential/mV
  Unextruded  37.7 ± 0.66  39.0 ± 9.60
  100 nm  28.4 ± 2.79  39.8 ± 4.26
Z-average/nm
  Unextruded 2664 ± 254.6 2690 ± 1137.5
  100 nm   559 ± 56.3   410 ± 88.4
Notes: Lipoplexes were prepared by hydration of thin lipid film with pEGFP solution, 
which  were  extruded  through  membranes  with  100  nm  pores.  Measurements 
were performed in PBS, and the final concentration was 0.125 mg/mL. Results are 
expressed as mean ± standard deviation of three separate experiments. Each sample 
was measured three times. 
Abbreviations: pEGFP, plasmid (encoding) enhanced green fluorescent protein; 
PC, phosphatidylcholine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; 
DOTAP, N-(1-(2,3-dioleoyloxy)propyl),N,N,N-trimethylammonium chloride; CHOL, 
cholesterol; PBs, phosphate-buffered saline.
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imply that increase in size (above 1000 nm) of the complex 
is the major determinant of in vitro transfection leading to 
improvement of efficiency.12 Others showed that the high 
transfection activity correlates with the presence of com-
plexes of sizes in the range 650–1500 nm.37 Also it has been 
shown that the type of endocytosis (clathrin or caveolae 
mediated) is size dependent and influences the type of pro-
cessing in the cell. Particles about 500 nm in size are endo-
cytosized by a caveolae-mediated process which does not 
lead to a degradative pathway in contrast to particles smaller 
than 200 nm that undergo clathrin-dependent endocytosis 
leading to lysosomal degradation.11 This means that com-
plexes smaller than 500 nm would be able to deliver nucleic 
acids to cytoplasm only if they were able to exit the endo-
some, whereas those larger than 500 nm would be more 
favorable for delivery. Our results show that the transfection 
efficiency in vitro increased with the increasing charge ratio 
and decreasing size in the case of PC-DOPE-DOTAP and 
DOPE-DOTAP (Figure 3), but it is important to say that size 
was decreased only to about 500 nm. The effect of charge 
ratio is however evident with unextruded PC-DOPE-DOTAP 
lipoplexes where mean diameter is above 4 µm for all charge 
ratios and the highest transfection efficiency is achieved with 
the highest charge ratio. In addition, transfection efficiency 
of extruded lipoplexes is also charge ratio dependent in the 
same manner (Figure 3), although size differences are more 
pronounced in this case and should be considered.   Apparently, 
both the effect of size reduction and increase in charge ratio 
influence the transfection efficiency but also each other as 
shown in Figure 1. Taken together, it might be concluded 
that increase in charge ratio ie, charge density, is contributing 
to transfection efficiency most probably due to stronger 
interaction with the cell membrane or easier escape from the 
endosome (since charge density was shown to correlate with 
endosome escape).20 Formulations containing CHOL showed 
the smallest transfection efficiency in comparison to DOPE-
containing formulations as is usually the case in in vitro 
experiments. In addition, CHOL-containing formulations 
showed only slight enhancement of transfection efficiency 
following size reduction. It can be concluded that, in the 
experimental conditions used, increase in charge ratio leads 
to enhancement of transfection efficiency and together with 
size reduction (also influenced by charge ratio) leads to more 
efficient formulations for delivery of nucleic acids. Finally, 
we tested cytotoxicity of the formulations used for transfec-
tion and found that PC-CHOL-DOTAP, PC-DOPE-DOTAP, 
and DOPE-DOTAP all at charge ratio 50 are the most toxic 
probably due to the large amounts of DOTAP. These formu-
lations had much higher concentrations of DOTAP (5 mM) 
than those shown to be nontoxic for cells (CaSki) 40 µM but 
this was required for obtaining high charge ratios.38
Conclusion
Our results indicate that the reduction of the size and increase 
in charge ratio of liposome/DNA complexes promotes trans-
fection efficiency but unfortunately also induces higher 
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Figure 4 Cytotoxicity of complexes determined by MTT assay.
Notes: Results are expressed as mean ± standard deviation of at least three separate experiments. Number in brackets denotes the charge ratio.
Abbreviations:  PC,  phosphatidylcholine;  DOPE,  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine;  DOTAP,  N-(1-(2,3-dioleoyloxy)propyl),N,N,N-trimethylammonium 
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  cytotoxicity due to the higher amounts of cationic lipid 
DOTAP. Also, we have demonstrated that the size of lipo-
some/DNA complexes after extrusion through certain pore 
sizes is reduced to some extent but is strongly governed by 
the charge ratio. This emphasizes the complex relationship 
of liposome properties and activity and the necessity for 
further experiments studying mechanism of action of 
  liposome-based transfection and liposome characteristics 
promoting transfection to achieve effective and safe nucleic 
acids delivery.
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